Page 3 - SOUTH FLORIDA HOPSITAL NEWS APRIL 2022
P. 3

r
                                                             I
               M      i am       i  C     an      c  e n                         t u t i t s        s ’ e t

                                                                              he A
               T           r i h  d S    u    mm           i           fth                     m     e         c i r  a          s
                                                     m t o

                           I
                                                       th r
                             m
               on          I mu                n       t ot h  e      a   pi     e          fo f                  r
                                                                               i s
               H     em                    l o t a  ogic                 l a  ig  n    a   nc         e i  s s
                                                        c M










                                                             In the United States, approximately 1
                                                                                                          y 186,400 people are
                                                             expected to be diagnosed with leu             kemia, lymphoma, myeloma
                                                                                                           according to the American
                                                             and other blood cancers this year, a
                                                             Cancer Society. Thousands more a
                                                                                                          are already in treatment.
                                                                                                         erts will gather for the third
                                                             In April 2022, the nation’s top expe
                                                             Miami Cancer Institute Summit of A
                                                                                                         Americas on Immunotherapies
                                                                                                          rovideanoverviewandd
                                                             for Hematologic Malignancies to pr            o v i d e an o v e r v i e w  an
                                                             opportunity to learn about the most recent advances in the
                                                             treatment of acute myeloid leukemia, acute lymphoid leukemia,

                                                             multiple myeloma, non-Hodgkin’s lymphoma, allogenic stem


                                                             cell transplants and CAR                            TT--cells.

                                                             Updates on evolving immunologically and molecular-                    b



                                                                                                                                 r-based
                                                             system therapies will be profiled and discussed. “By ddiscussing
                                                             the most recent research, we move science forward, ultimately
                                                                                                                                  o
                                                                            , .        offering more options to patients and improving their outcomes,”
                   G u en  h t  er  K o eh n  , e   M .D  , .   P h .D
                                                                                                                                   .
                   D e p  t u  y D  e r i  o t c  r a n d C  e i h  f o                        f       said symposium director Guenther Koehne, M.D., Ph.D., deputy
                                      Tr
                    l B  ood a n d M  o r r a  w T ra n s  a l p                        t n        director of Miami Cancer Institute, part of Baptist Health,
                                                                                                                                  a
                   a n d H e m  l o t a  og i c O n c  l o  ogy                        ,
                                                                                                                                  a
                   M  a i  m i C a n ce r I n  e t u t i t s  and chief of Blood and Marrow Transplant and Hematologic
                                                             Oncology and champion of the Summit.


                                                    Liive Symposium




                                           Friday-Saturday, April 8-9, 2022
                                                       y

                                   The Ritz-CCarlton Coconut Grove, Miami




                                       Summit Director: Guenther Koehne, M.D., Ph.D.

                               For more information, please visit MiamiCancerInstitute.com/HematologicMalignancies.
                                                                     a
                                                   Join thhe conversattion: #MCIImmunotherapySummit


















        South Florida Hospital News                                                              southfloridahospitalnews.com                                                              April 2022                            3
   1   2   3   4   5   6   7   8